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Prognostic Significance of Epicardial Blood
Flow Before and After Percutaneous Coronary
Intervention in Patients With Acute Coronary Syndromes
Gjin Ndrepepa, MD,* Julinda Mehilli, MD,* Stefanie Schulz, MD,* Raisuke Iijima, MD,*
Dritan Keta, MD,* Robert A. Byrne, MD,* Jürgen Pache, MD,* Melchior Seyfarth, MD,*
Albert Schömig, MD,*† Adnan Kastrati, MD*
Munich, Germany
Objectives The aim of the study was to assess the relationship between baseline and post-procedural Thrombolysis In Myo-
cardial Infarction (TIMI) epicardial blood flow grade and mortality in patients with acute coronary syndromes
(ACS) who were treated with early percutaneous coronary intervention (PCI).
Background The impact of baseline and post-procedural TIMI flow grade on mortality in patients with ACS has been insuffi-
ciently studied.
Methods This prospective registry included 10,455 patients with ACS who underwent coronary angiography and PCI:
2,853 patients with ST-segment elevation acute myocardial infarction, 3,060 patients with non–ST-segment ele-
vation acute myocardial infarction, and 4,542 patients with unstable angina. The primary outcome was 1-year
mortality.
Results At 1 year, there were 976 deaths: 117 deaths among patients with TIMI flow grade 0 to 1, 105 deaths among
patients with TIMI flow grade 2, and 754 deaths among patients with TIMI flow grade 3 (Kaplan-Meier estimates
of mortality 28.3%, 18.4%, and 8.0%, respectively; odds ratio: 1.66, 95% confidence interval [CI]: 1.57 to 1.76,
p  0.001, for TIMI flow grade 0 to 1 vs. TIMI flow grade 2 and odds ratio: 2.51, 95% CI: 2.06 to 3.06, p 
0.001, for TIMI flow grade 2 vs. TIMI flow grade 3). By using the Cox proportional hazards survival model, we
identified post-PCI TIMI flow grade (hazard ratio: 0.60, 95% CI: 0.52 to 0.70; p  0.001, for 1 grade increase in
TIMI flow grade) but not baseline TIMI grade (hazard ratio: 1.08, 95% CI: 0.96 to 1.22; p  0.20, for 1 grade
increase in TIMI flow grade) as an independent correlate of 1-year mortality.
Conclusions In patients with ACS treated with early PCI, post-procedural TIMI flow grade but not baseline TIMI flow grade is
an independent correlate of 1-year mortality. (J Am Coll Cardiol 2008;52:512–7) © 2008 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.05.009p
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Phe completeness of restoration of the epicardial blood flow
fter recanalization of infarct-related artery has been quan-
ified with the Thrombolysis In Myocardial Infarction
TIMI) grading system (1). The beneficial effects of full
estoration of the epicardial coronary flow (TIMI flow grade
) and the detrimental effects of failure to restore epicardial
oronary flow (TIMI 0 to 1) are well known (2). However,
ontroversy still exists with regard to outcomes in patients
ith partial restoration of the epicardial coronary flow
TIMI flow grade 2) after reperfusion therapy (3–7). In the
ast, restoration of TIMI flow grade 2 was considered as
rom *Deutsches Herzzentrum and †1. Medizinische Klinik rechts der Isar, Tech-
ische Universität, Munich, Germany.u
Manuscript received March 10, 2008; revised manuscript received April 28, 2008,
ccepted May 5, 2008.rocedural success (3,4), and the results were reported with
IMI flow grades 2 and 3 grouped together. Later, after it
as demonstrated that results in patients with TIMI flow
rade 2 did not differ from those in patients with TIMI flow
rade 0 to 1 (5–7) or were even worse (8), TIMI flow grade
was considered as suboptimal reperfusion and grouped
ogether with TIMI flow grade 0 to 1 as TIMI flow grade
2 (9–12). We undertook this study to assess the relation-
hip between baseline and post-procedural TIMI flow grade
nd 1-year mortality in patients with acute coronary syn-
romes (ACS) undergoing percutaneous coronary interven-
ion (PCI).
ethods
atients. This prospective registry included 10,455 consec-
tive patients with ACS who underwent diagnostic coro-
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August 12, 2008:512–7 TIMI Blood Flow and Mortalityary angiography and PCI in the Deutsches Herzzentrum
nd 1. Medizinische Klinik rechts der Isar between Sep-
ember 1997 and December 2006: 2,853 patients with
T-segment elevation acute myocardial infarction, 3,060
atients with non–ST-segment elevation acute myocardial
nfarction, and 4,542 patients with unstable angina.
ngiographic evaluation and stent implantation. Coro-
ary angiography was performed according to standard
riteria. Angiographic data were analyzed with the same
uantitative Angiographic Core Laboratory. Coronary ar-
ery disease was confirmed by the presence of coronary
tenoses50% lumen obstruction in at least 1 of the 3 main
oronary arteries. A culprit lesion was described in the
resence of an acute occlusion, intraluminal filling defects
or thrombus), ulcerated plaques with a contrast-filled
ocket protruding into plaque with or without delayed
ontrast wash-out, extraluminal contrast, dissection, or in-
raluminal flaps (13). Offline analysis of digital angiograms
as performed in the core laboratory with an automated
dge detection system (CMS, Medis Medical Imaging
ystems, Neuen, the Netherlands). The initial and post-
rocedural blood flow in the artery owning the culprit lesion
as quantified with the TIMI grading system (1). Stent
mplantation and periprocedural care were performed ac-
ording to standard criteria. Bare-metal stents were mostly
sed. Post-interventional antiplatelet therapy consisted of
iclopidine (500 mg/day) or clopidogrel (300 or 600 mg as
loading dose followed by 75 mg/day for at least 4 weeks to
months) and aspirin (200 mg/day administered orally and
ontinued indefinitely).
nd point and follow-up. The primary outcome of this
nalysis was 1-year mortality. The occurrence of myocardial
nfarction also was assessed. The follow-up protocol after
ischarge consisted of a phone interview at 1 month after
he procedure, a visit at 6 months, and a phone interview at
2 months. Information about death was obtained from
ospital records, death certificates, or phone contact with
elatives of the patient or attending physician. The diagnosis
f myocardial infarction was made according to the TIMI
riteria (1).
Patients were advised to present to the outpatient clinic or
heir referring physicians if they developed chest pain or other
ardiac symptoms. In case of symptoms, at least 1 clinical,
aboratory, or electrocardiographic check-up was performed.
tatistical analysis. Data are presented as median (25th;
5th percentiles) or counts and proportions (percentages).
he distribution of the data was analyzed with the 1-sample
olmogorov-Smirnov test. Categorical data were compared
ith the chi-square test. Continuous data were compared
ith the Kruskal-Wallis test. Survival analysis was per-
ormed by applying the Kaplan-Meier method. Differences
n survival were assessed with the log-rank test. The Cox
roportional hazards survival model was used to assess the
ssociation of the TIMI flow grade with 30-day and 1-year
ortality while adjusting for potential confounders. Vari-bles entered into the model were age, gender, diabetes, (rterial hypertension, smoking,
ypercholesterolemia, previous
yocardial infarction, previous
oronary artery bypass surgery,
linical presentation, cardiogenic
hock, serum creatinine, left ven-
ricular ejection fraction, extent
f coronary artery disease, type of
essel, culprit lesion location,
essel size, glycoprotein IIb/IIIa
nhibitors, baseline TIMI flow
rade, and post-PCI TIMI flow
rade. Analyses were performed
ith the S-plus statistical package (S-PLUS, Insightful
orp., Seattle, Washington). A p value 0.05 was consid-
red to indicate statistical significance.
esults
total of 10,455 patients with ACS underwent coronary
ngiography and were treated with PCI. In 9,217 patients
88.2%), coronary stents were implanted; the remaining
,238 patients (11.8%) were treated with balloon angio-
lasty. Because there were no significant differences in
-year mortality among patients with post-PCI TIMI flow
rade 0 or 1 (26% vs. 34%), these patients were grouped
ogether as TIMI flow grade 0 to 1. Baseline characteristics
ccording to post-procedural TIMI flow grade are shown in
able 1. Patients with a post-PCI TIMI flow grade 0 to 1
ere older and were more likely to be diabetic, to have had
revious myocardial infarction or previous coronary artery
ypass surgery, and they presented more often with cardio-
enic shock and had greater levels of troponin than patients
ith a TIMI flow grade 2 or 3. Hypercholesterolemia was
bserved slightly less often in patients with a TIMI flow
rade 0 to 1 compared with 2 other TIMI flow grade
roups. Other baseline characteristics that differed signifi-
antly among patients with various TIMI flow grades were
rterial hypertension, clinical presentation, creatine kinase-
yocardial band activity, and creatinine level.
Angiographic data are shown in Table 2. Patients with a
IMI flow grade 0 to 1 had more reduced left ventricular
ystolic function and had a greater proportion of patients
ith multivessel disease and a baseline TIMI flow grade 0 to
than patients with TIMI flow grades 2 or 3. Figure 1
hows the relationship between baseline and post-PCI
IMI flow grades.
utcome according to baseline TIMI flow grade. There
ere 3,511 patients with baseline TIMI flow grade 0 to 1,
,864 patients with baseline TIMI flow grade 2, and 5,080
atients with TIMI flow grade 3. At 30 days, there were
02 deaths among patients with TIMI flow grade 0 to 1,
02 deaths among patients with TIMI flow grade 2, and
54 deaths among patients with TIMI flow grade 3
Abbreviations
and Acronyms
ACS  acute coronary
syndromes
CI  confidence interval
HR  hazard ratio
OR  odds ratio
PCI  percutaneous
coronary intervention
TIMI  Thrombolysis In
Myocardial InfarctionKaplan-Meier estimates of mortality, 8.6%, 5.5%, and
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TIMI Blood Flow and Mortality August 12, 2008:512–7.0%, respectively; odds ratio [OR]: 1.60, 95% confidence
nterval [CI]: 1.48 to 1.74, p  0.001 for TIMI flow grade
to 1 vs. TIMI flow grade 2 and OR: 1.85, 95% CI: 1.43
o 2.39, p  0.001 for TIMI flow grade 2 vs. TIMI flow
rade 3). There were no significant differences in the
aseline Characteristics According to Post-PCI TIMI Flow Grade
Table 1 Baseline Characteristics According to Post-PCI TIMI F
Characteristic
TIMI Flow Grad
(n  414
Age (yrs) 70.2 [60.8; 7
Women 118 (28.5
Body mass index (kg/m2) 26.2 [24.5; 2
Diabetes 140 (33.8
On insulin therapy 54 (13.0
Arterial hypertension 321 (77.5
Current smoking 93 (22.5
Hypercholesterolemia (240 mg/dl) 242 (58.5
Previous myocardial infarction 140 (33.8
Previous coronary artery bypass surgery 77 (18.6
Clinical presentation
ST-segment elevation acute myocardial infraction 148 (35.7
Non–ST-segment elevation acute myocardial infraction 172 (41.6
Unstable angina 94 (22.7
Cardiogenic shock 74 (17.9
Creatine kinase-myocardial band (U/l) 33.6 [15.0; 7
Troponin T level (g/l) 0.38 [0.05; 1
Serum creatinine (mg/dl) 1.1 [0.9; 1
ata are median [25th; 75th percentiles] or numbers of patients (%).
PCI  percutaneous coronary intervention; TIMI  Thrombolysis In Myocardial Infarction.
ngiographic Data According to Post-PCI TIMI Flow Grade
Table 2 Angiographic Data According to Post-PCI TIMI Flow Gr
Characteristic
TIMI Flow Grade 0
(n  414)
Left ventricular ejection fraction 45.0 [31.0; 56.0
Extent of coronary artery disease
1-vessel disease 80 (19.3)
2-vessel disease 83 (20.0)
3-vessel disease 251 (60.7)
Multivessel disease 334 (80.7)
Vessel treated
Left main coronary artery 4 (1.0)
Left anterior descending coronary artery 125 (30.2)
Left circumflex coronary artery 96 (31.2)
Right coronary artery 145 (35.0)
Bypass graft 44 (10.6)
Vessel size (mm) 2.63 [2.29; 3.10
Culprit lesion location
Proximal 132 (31.9)
Medial 182 (44.0)
Distal 100 (24.1)
TIMI flow grade before PCI
0 315 (76.1)
1 42 (10.1)
2 31 (7.5)
3 26 (6.3)
Periprocedural use of glycoprotein IIb/IIIa inhibitors 179 (43.2)ata are median [25th; 75th percentiles] or numbers of patients (%).
Abbreviations as in Table 1.ccurrence of myocardial infarction within the first 30
ays after PCI according to baseline TIMI flow grade
2.2% [n  77] in TIMI flow grade 0 to 1, 2.4% [n  45]
n TIMI flow grade 2, and 2.1% [n  105] in TIMI flow
rade 3).
rade
1 TIMI Flow Grade 2
(n  570)
TIMI Flow Grade 3
(n  9,471) p Value
67.0 [58.9; 74.8] 66.0 [57.1; 74.2] 0.001
139 (24.4) 2,458 (26.0) 0.34
26.5 [24.5; 29.3] 26.4 [24.3; 29.1] 0.72
140 (24.6) 2,338 (24.7) 0.001
42 (7.3) 734 (7.7) 0.001
410 (71.9) 7,220 (76.2) 0.05
163 (28.6) 2,555 (27.0) 0.08
345 (60.5) 6,037 (63.7) 0.03
158 (27.7) 2,669 (28.2) 0.04
89 (15.6) 1,027 (10.8) 0.001
0.001
281 (49.3) 2,424 (25.5)
127 (22.3) 2,761 (29.2)
162 (28.4) 4,286 (45.3)
81 (14.2) 52 (5.6) 0.001
46.2 [19.0; 123.5] 21.0 [12.8; 54.0] 0.001
0.35 [0.08; 1.56] 0.07 [0.01; 0.51] 0.001
1.1 [0.9; 1.3] 1.0 [0.9; 1.2] 0.001
TIMI Flow Grade 2
(n  570)
TIMI Flow Grade 3
(n  9,471) p Value
47.6 [36.0; 57.0] 54.0 [43.0; 61.3] 0.001
0.001
145 (25.4) 2,496 (26.4)
176 (30.9) 2,737 (28.9)
259 (43.7) 4,238 (44.7)
425 (74.6) 6,975 (73.6) 0.006
0.001
14 (2.4) 218 (2.3)
217 (38.1) 3,939 (41.6)
115 (20.2) 2,061 (21.7)
169 (29.6) 2,810 (29.7)
55 (9.7) 443 (4.7)
2.97 [2.60; 3.39] 2.88 [2.51; 3.24] 0.001
0.001
205 (36.0) 3,768 (39.8)
280 (49.1) 4,156 (43.9)
85 (14.9) 1,547 (16.3)
0.001
288 (50.5) 2,133 (22.5)
70 (12.3) 663 (7.0)
108 (19.0) 1,725 (18.2)
104 (18.2) 4,950 (52.3)
329 (57.7) 3,835 (40.5) 0.001low G
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August 12, 2008:512–7 TIMI Blood Flow and MortalityAt 1 year, there were 425 deaths among patients with TIMI
ow grade 0 to 1, 187 deaths among patients with TIMI flow
rade 2, and 364 deaths among patients with TIMI flow grade
(Kaplan-Meier estimates of mortality, 12.1%, 10.0%, and
.2%, respectively; OR: 1.23, 95% CI: 1.17 to 1.30, p 
.001 for TIMI flow grade 0 to 1 vs. TIMI flow grade 2 and
R: 1.44, 95% CI: 1.19 to 1.73, p  0.001 for TIMI flow
rade 2 vs. TIMI flow grade 3. Again, there were no
ignificant differences in the occurrence of myocardial in-
arction within the first year after PCI according to baseline
IMI flow grade (3.3% [n  116] in TIMI flow grade 0 to
, 3.4% [n 64] in TIMI flow grade 2 and 3.1% [n 160]
n TIMI flow grade 3).
There were 3,209 patients with TIMI flow grade 0 to 1,
,762 patients with TIMI flow grade 2, and 4,926 patients
ith TIMI flow grade 3 who survived the first month after
CI. Between 1 and 12 months after PCI, there were 123
eaths among patients with TIMI flow grade 0 to 1, 85
eaths patients among patients with TIMI flow grade 2,
Baseline TIMI flow 
Post-PCI TIMI flow 
TIMI 0-1 
n = 3511 
TIMI 2 
n = 1864
TIMI 3 
n = 5080 
TIMI 0-1 
n = 414 
TIMI 2 
n = 570
TIMI 3 
n = 9471 
357
31
6972 62
1725
4950104
108
358
Figure 1 Baseline and Post-PCI TIMI Grades
Relationship between baseline TIMI flow grade and TIMI flow grade immediately
after PCI. PCI  percutaneous coronary intervention; TIMI  Thrombolysis In
Myocardial Infarction.
Thirty-Day and 1-Year Outcome According to Po
Table 3 Thirty-Day and 1-Year Outcome Acc
Characteristic
TIMI Flow Grade 0 to
(n  414)
30-day outcome
Death 92 (22.2)
Nonfatal myocardial infarction 23 (5.6)
Death or myocardial infarction 109 (26.3)
1-yr outcome
Death 117 (28.3)
Nonfatal myocardial infarction 27 (6.5)
Death or myocardial infarction 135 (32.6)
Deaths from 1 month to 1 yr* 25 (7.8)
Data are counts (%) for 30-day outcome and counts and Kaplan-Meier
first month after PCI (322 patients in the group with TIMI flow grade 0
the group with TIMI flow grade 3).
Abbreviations as in Table 1.nd 210 deaths among patients with TIMI flow grade 3
Kaplan-Meier estimates 3.2%, 4.8%, and 4.3%, respec-
ively; OR: 0.79, 95% CI: 0.60 to 1.04, p  0.25 for TIMI
ow grade 0 to 1 vs. TIMI flow grade 2 and OR: 1.14, 95%
I: 0.88 to 1.47, p 0.32, for TIMI flow grade 2 vs. TIMI
ow grade 3).
0-day outcome according to post-PCI TIMI flow grade.
he 30-day outcome of patients according to the TIMI
ow grades is shown in Table 3 (first part). The propor-
ions of patients who died or had reinfarction were
ecreased with the increase in the post-PCI TIMI flow
rade from grade 0 to 1 to grade 3. Table 4 shows ORs
ith 95% CI regarding 30-day outcome in groups with a
IMI flow grade 0 to 1 vs. TIMI flow grade 2 and TIMI
ow grade 2 versus TIMI flow grade 3.
-year outcome according to post-PCITIMIflowgrade. The
-year outcome is shown in Table 3. At 1 year, there were
17 deaths among patients with TIMI flow grade 0 to 1,
05 deaths among patients with TIMI flow grade 2, and
54 deaths among patients with TIMI flow grade 3
Kaplan-Meier estimates of mortality 28.3%, 18.4%, and
.0%, respectively; OR: 1.66, 95% CI: 1.57 to 1.76, p 
.001 for TIMI flow grade 0 to 1 vs. TIMI flow grade 2 and
R: 2.51, 95% CI: 2.06 to 3.06, p  0.001 for TIMI flow
rade 2 vs. TIMI flow grade 3) (Table 4, Fig. 2). Table 4
hows ORs (95% CIs) regarding 1-year outcome in groups
ith a TIMI flow grade 0 to 1 versus TIMI flow grade 2
nd TIMI flow grade 2 versus TIMI flow grade 3.
esults of multivariable analysis. The Cox proportional
azards survival model was used to test the association of
IMI flow grade with 30-day and 1-year mortality (see
ethods section for variables entered into the model). The
odel showed that post-PCI TIMI flow grade was an
ndependent correlate of 30-day mortality (hazard ratio
HR]: 0.59, 95% CI: 0.49 to 0.71; p  0.001, for 1 grade
ncrease in TIMI flow grade) and of 1-year mortality (HR:
.60, 95% CI: 0.52 to 0.70; p  0.001, for 1 grade increase
n TIMI flow grade). Baseline TIMI flow grade was not an
ndependent correlate of either 30-day mortality (HR: 0.88,
I TIMI Flow Grade
g to Post-PCI TIMI Flow Grade
TIMI Flow Grade 2
(n  570)
TIMI Flow Grade 3
(n  9,471) p Value
74 (13.0) 392 (4.1) 0.001
30 (5.3) 174 (1.8) 0.001
101 (17.7) 557 (5.9) 0.001
105 (18.4) 754 (8.0) 0.001
35 (6.2) 278 (2.9) 0.001
132 (23.2) 972 (10.3) 0.001
31 (6.3) 362 (4.0) 0.001
tes (%) for 1-year outcome. *Calculated for patients who survived the
6 patients in the group with TIMI flow grade 2, and 9,079 patients forst-PC
ordin
1
estima
to 1, 49
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TIMI Blood Flow and Mortality August 12, 2008:512–75% CI: 0.74 to 1.05; p  0.15, for 1 grade increase in
IMI flow grade) or 1-year mortality (HR: 1.08, 95% CI:
.96 to 1.22; p  0.20, for 1 grade increase in TIMI flow
rade). There was no significant interaction between base-
ine TIMI flow grade and ACS form in predicting 1-year
ortality (p  0.26).
iscussion
n this study, we investigated the relationship between
IMI flow grade achieved after PCI (mostly coronary
tenting) and mortality in a large prospective registry,
ncluding more than 10,000 patients with ACS. A unique
haracteristic of this registry is that all patients were treated
ith PCI. The main findings of this study are as follows:
) Post-PCI TIMI flow grade was strongly associated with
0-day and 1-year mortality in patients with ACS. The
ssociation between post-PCI TIMI flow and mortality is
0
5
15
25
30
0 1 2 3 4 5 6 7 8 9 10 11 12
P
ro
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y
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 D
ea
th
, %
20
10
Months after Admission
Numbers at risk
TIMI grade 0-1
TIMI grade    2
TIMI grade    3
414
570
9471
314
489
9010
308
481
8920
305
475
8851
304
470
8792
301
466
8747
297
465
8717
TIMI flow grade 3
TIMI flow grade 2
TIMI flow grade 0-1
OR = 1.66 [95% CI 1.57-1.76]; P<0.001
OR = 2.51 [95% CI 2.06-3.06]; P<0.001
Figure 2 1-Year Mortality According
to Post-PCI TIMI Flow Grade
Kaplan-Meier curves of 1-year mortality in patients according to post-PCI TIMI
flow grades. CI  confidence interval; OR  odds ratio; other abbreviations as
in Figure 1.
Odds Ratio (95% CI) for TIMI Flow Grade 0 to 1Flow Gr de 2 and TIMI Flow Grade 2 Versus TIM
Table 4 Odds Ratio (95% CI) for TIMI FlowFlow Grade 2 and TIMI Flow Grade
Characteristic
TIMI Flow Grade 0 to 1
TIMI Flow Grade 2
30-day outcome
Death 1.81 (1.70–1.92)
Myocardial infarction 1.06 (1.04–1.07)
Death or myocardial
infarction
1.66 (1.22–2.25)
1-yr outcome
Death 1.66 (1.57–1.76)
Myocardial infarction 1.06 (1.04–1.09)
Death or myocardial
infarction
1.52 (1.45–1.59)
Deaths from 1 month to 1 yr 1.25 (1.12–1.39)
CI  confidence interval; other abbreviations as in Table 1.ondependent of cardiovascular risk factors or clinical char-
cteristics, including baseline TIMI grade and ACS presen-
ation. 2) Patients with TIMI flow grade 2 have mortality
ates intermediate to those of patients with TIMI flow
rade 0 to 1 and TIMI flow grade 3. 3) Although baseline
IMI flow grade predicts 30-day and 1-year mortality (in
nivariate analysis), an adjustment in the multivariable
odel for other characteristics, including post-PCI TIMI
ow grade, attenuated the strength of association to the
evel of statistical insignificance. A separate analysis of
eaths within the first 30 days and from 1 month to 1 year
howed that baseline TIMI flow grade affected early (30-
ay) mortality, but it did not influence subsequent mortality
rom 1 month to 1 year after PCI.
Findings regarding the impact of the baseline and post-
rocedural TIMI flow grade on mortality deserve attention.
e observed an association between baseline TIMI flow
rade and 30-day and 1-year mortality. Furthermore, sep-
rate analyses of deaths occurring within the first 30 days
nd 1-month to 1-year time intervals showed that baseline
IMI flow grade affected 30-day mortality but it did not
ffect deaths occurring 1 month to 1 year after PCI. After
djustment in the multivariable analysis for other potential
onfounders, including post-PCI, the baseline TIMI flow
rade was not an independent correlate of either 30-day or
-year mortality. This finding is at variance with some
revious studies of patients with acute myocardial infarction
ndergoing PCI in which baseline TIMI flow grade pre-
icted early and late survival (11,14). It has to be stressed
hat, in both these studies, the baseline TIMI flow grade-
ortality association was at the edge of statistical signifi-
ance and that TIMI flow grades2 were grouped together
nd compared with TIMI flow grade 3 (11,14). Instead, in
ur study, the association between baseline TIMI flow grade
nd mortality was assessed for 1 grade difference in TIMI
ow.
Theoretically, differences in patient populations between
us TIMIw Grade 3
0 to 1 Versus TIMI
sus TIMI Flow Grade 3
Odds Ratio (95% CI)
p Value
TIMI Flow Grade 2 Versus
TIMI Flow Grade 3 p Value
0.001 3.32 (2.63–4.20) 0.001
0.001 2.93 (2.03–4.25) 0.001
0.001 3.44 (2.73–4.34) 0.001
0.001 2.51 (2.06–3.06) 0.001
0.001 2.15 (1.52–3.03) 0.001
0.001 2.51 (2.10–2.99) 0.001
0.001 1.59 (1.10–2.78) 0.012VersI Flo
Grade
2 Ver
Versusur study (patients with ACS) and these studies (patients
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August 12, 2008:512–7 TIMI Blood Flow and Mortalityith acute myocardial infarction) could be another source of
iscrepancy. Scintigraphic studies have shown that pre-
erved blood flow in the infarct-related in patients with
cute myocardial infarction is associated with a smaller area
t risk, a smaller infarct, and better recovery of left ventric-
lar function (15). However, we did not find any significant
nteraction between baseline TIMI flow grade and ACS
orm in predicting mortality. Finally, there is a possibility
hat the association between baseline TIMI flow grade and
utcome may be overridden by a high rate of TIMI flow
rade 3 achieved with PCI.
onclusions
ata from this large prospective registry of patients with
CS undergoing PCI showed that post-procedural TIMI
ow grade but not baseline TIMI flow grade was an
ndependent predictor of 1-year mortality. Patients with a
ost-PCI TIMI flow grade 2 showed a mortality that was
ntermediate between that of patients with TIMI flow
rades 0 to 1 and 3.
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